$250.10
À la fermeture: Nov 10 EDT
$250.50
0.400.16%
Pré-commercialisation: 6:14 PM EDT
Comments
Loading...
Estimations des bénéfices, EPS et revenus
ResMed publie ses résultats sur une base trimestrielle. Ces rapports trimestriels sur les résultats donnent aux investisseurs un aperçu des résultats financiers d'une entreprise sur une période de 3 mois. Les rapports sur les résultats incluent presque toujours les résultats du BPA et du chiffre d'affaires.
Date des bénéfices
janv. 29
Estimation de l'EPS
$2.700
Estimation du chiffre d'affaires trimestriel
$1.39B
Chiffre d'affaires annuel
(à partir de sept. 30)
(à partir de sept. 30)
$5.26B
Analysez l'historique des bénéfices de ResMed en utilisant des tris et des filtres avancés.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
RMD | ResMed | $2.43 | $2.70 | — | — | $1.28B | $1.39B | — | — | 01/29/2026 | |
RMD | ResMed | $2.20 | $2.50 | $2.55 | 2.00% | $1.23B | $1.33B | $1.34B | 0.62% | 10/30/2025 | |
RMD | ResMed | $2.08 | $2.47 | $2.55 | 3.24% | $1.22B | $1.33B | $1.35B | 1.63% | 07/31/2025 | |
RMD | ResMed | $2.13 | $2.36 | $2.37 | 0.42% | $1.20B | $1.28B | $1.29B | 0.94% | 04/23/2025 | |
RMD | ResMed | $1.88 | $2.31 | $2.43 | 5.19% | $1.16B | $1.27B | $1.28B | 0.94% | 01/30/2025 | |
RMD | ResMed | $1.64 | $2.04 | $2.20 | 7.84% | $1.10B | $1.18B | $1.23B | 3.81% | 10/24/2024 | |
RMD | ResMed | $1.60 | $2.06 | $2.08 | 0.97% | $1.12B | $1.19B | $1.22B | 2.77% | 08/01/2024 | |
RMD | ResMed | $1.68 | $1.91 | $2.13 | 11.52% | $1.12B | $1.17B | $1.20B | 2.31% | 04/25/2024 | |
RMD | ResMed | $1.66 | $1.79 | $1.88 | 5.03% | $1.03B | $1.15B | $1.16B | 1.13% | 01/24/2024 | |
RMD | ResMed | $1.51 | $1.62 | $1.64 | 1.23% | $950.29M | $1.10B | $1.10B | 0.18% | 10/26/2023 | |
RMD | ResMed | $1.49 | $1.67 | $1.60 | -4.19% | $914.74M | $1.12B | $1.12B | 0.18% | 08/03/2023 | |
RMD | ResMed | $1.32 | $1.59 | $1.68 | 5.66% | $864.50M | $1.05B | $1.12B | 6.37% | 04/27/2023 | |
RMD | ResMed | $1.47 | $1.60 | $1.66 | 3.75% | $894.87M | $994.02M | $1.03B | 4.02% | 01/26/2023 | |
RMD | ResMed | $1.51 | $1.52 | $1.51 | -0.66% | $904.01M | $941.17M | $950.29M | 0.97% | 10/27/2022 | |
RMD | ResMed | $1.35 | $1.51 | $1.49 | -1.32% | $876.10M | $912.97M | $914.74M | 0.19% | 08/11/2022 | |
RMD | ResMed | $1.30 | $1.42 | $1.32 | -7.04% | $768.77M | $897.04M | $864.50M | -3.63% | 04/28/2022 | |
RMD | ResMed | $1.41 | $1.52 | $1.47 | -3.29% | $800.01M | $935.25M | $894.87M | -4.32% | 01/27/2022 | |
RMD | ResMed | $1.27 | $1.36 | $1.51 | 11.03% | $751.94M | $866.33M | $904.01M | 4.35% | 10/28/2021 | |
RMD | ResMed | $1.33 | $1.28 | $1.35 | 5.47% | $770.34M | $783.18M | $876.10M | 11.86% | 08/05/2021 | |
RMD | ResMed | $1.29 | $1.28 | $1.30 | 1.56% | $769.46M | $801.83M | $768.77M | -4.12% | 04/29/2021 | |
RMD | ResMed | $1.21 | $1.26 | $1.41 | 11.90% | $736.16M | $783.18M | $800.01M | 2.15% | 01/28/2021 |
ResMed (RMD) Bénéfice par action
Montant surprise des bénéfices trimestriels
| Trimestre Fiscal | Date de Déclaration | BPA Réel | BPA Estimé | Surprendre % |
|---|---|---|---|---|
| Q1 | 2025-10-30 | $2.55 | $2.50 | 2.00 % |
| Q4 | 2025-07-31 | $2.55 | $2.47 | 3.24 % |
| Q3 | 2025-04-23 | $2.37 | $2.36 | 0.42 % |
| Q2 | 2025-01-30 | $2.43 | $2.31 | 5.19 % |
Chiffre d'affaires de ResMed (RMD)
Montant surprise des revenus trimestriels
| Trimestre Fiscal | Date de Déclaration | Revenu Réel | Revenu Estimé | Surprendre % |
|---|---|---|---|---|
| Q1 | 2025-10-30 | $1.34B | $1.33B | 0.62 % |
| Q4 | 2025-07-31 | $1.35B | $1.33B | 1.63 % |
| Q3 | 2025-04-23 | $1.29B | $1.28B | 0.94 % |
| Q2 | 2025-01-30 | $1.28B | $1.27B | 0.94 % |
FAQ
Quand ResMed (NYSE:RMD) va-t-il publier ses résultats ?
ResMed (RMD) est prévu pour annoncer ses bénéfices le janvier 29, 2026. Les derniers bénéfices rapportés étaient pour Q1 le octobre 30, 2025.
Quels ont été les derniers bénéfices par action (BPA) pour ResMed (NYSE:RMD) ?
Le BPA réel était de $2.55, ce qui dépassé l'estimation de $2.50.
Quels étaient les revenus de ResMed (NYSE:RMD) ?
Le chiffre d'affaires réel était de $1.3B, ce qui dépassé l'estimation de $1.3B.
Parcourir estimations des bénéfices, EPS et chiffre d'affaires sur toutes les actions.